患者报告的原发性副甲状腺功能障碍的结局措施:测量属性的系统性审查

George Liang1, Manraj N Kaur1,2, Carrie G Wade2

  • 1Patient-Reported Outcomes, Value, and Experience (PROVE) Center, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.

概括

对于原发性副甲状腺症 (PHPT) 的患者报告结果测量 (PROM) 缺乏足够的证据. 目前的PROM如SF-36,PAS和PHPQoL不能推,因为证据的确定性低,测量性能差.